DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Materials
Updated 4m ago
CEMENTOS logo

Cementos Bio Bio S.A.SNSE:CEMENTOS Stock Report

Market Cap CL$457.1b
Updated 4m ago
Share Price
n/a
1Y8.1%
7D0%
1D0%
Portfolio Value
​
View

Cementos Bio Bio S.A.

SNSE:CEMENTOS Stock Report

Market Cap: CL$457.1b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Cementos Bio Bio (CEMENTOS) Stock Overview

Engages in the production and sale of cement, lime, and concrete products in Chile and internationally. More details

CEMENTOS fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends3/6

Rewards

Trading at 17.8% below our estimate of its fair value

Earnings grew by 2% over the past year

Risk Analysis

Dividend of 4.62% is not well covered by earnings


CEMENTOS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW435,612 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
435,612 investors already sharing narratives
CL$
Current Price
CL$1.73k19.5% overvalued intrinsic discount
%/yr
Decrease
Increase
PastFuture0536b2016201920222025202620282031Revenue CL$535.7bEarnings CL$47.8b
Advanced
View all narratives

Cementos Bio Bio S.A. Competitors

Cemento Polpaico

Symbol: SNSE:POLPAICO
Market cap: CL$285.2b

Melon

Symbol: SNSE:MELON
Market cap: CL$190.0b

Compañía Industrial El Volcán

Symbol: SNSE:VOLCAN
Market cap: CL$233.1b

Oxiquim

Symbol: SNSE:OXIQUIM
Market cap: CL$313.6b

Price History & Performance

Summary of share price highs, lows and changes for Cementos Bio Bio
Historical stock prices
Current Share PriceCL$1,730.00
52 Week HighCL$2,001.00
52 Week LowCL$1,400.00
Beta-0.21
1 Month Change0%
3 Month Change0%
1 Year Change8.13%
3 Year Change173.19%
5 Year Change129.99%
Change since IPO440.63%

Recent News & Updates

Recent updates

Analysis Article • Nov 20

Market Might Still Lack Some Conviction On Cementos Bio Bio S.A. (SNSE:CEMENTOS) Even After 86% Share Price Boost

Cementos Bio Bio S.A. ( SNSE:CEMENTOS ) shareholders have had their patience rewarded with a 86% share price jump in...
Analysis Article • Nov 20

The Return Trends At Cementos Bio Bio (SNSE:CEMENTOS) Look Promising

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Analysis Article • Apr 08

Investors Shouldn't Be Too Comfortable With Cementos Bio Bio's (SNSE:CEMENTOS) Robust Earnings

Cementos Bio Bio S.A. ( SNSE:CEMENTOS ) announced strong profits, but the stock was stagnant. We did some digging, and...
Analysis Article • Jun 06

Capital Allocation Trends At Cementos Bio Bio (SNSE:CEMENTOS) Aren't Ideal

When researching a stock for investment, what can tell us that the company is in decline? Typically, we'll see the...
Analysis Article • May 10

Is Cementos Bio Bio (SNSE:CEMENTOS) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Mar 07

Shareholders Of Cementos Bio Bio (SNSE:CEMENTOS) Must Be Happy With Their 79% Return

Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...
Analysis Article • Feb 14

Be Wary Of Cementos Bio Bio (SNSE:CEMENTOS) And Its Returns On Capital

What underlying fundamental trends can indicate that a company might be in decline? Businesses in decline often have...
Analysis Article • Jan 19

Is Cementos Bio Bio (SNSE:CEMENTOS) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article • Dec 01

Cementos Bio Bio (SNSE:CEMENTOS) Has Compensated Shareholders With A Respectable 74% Return On Their Investment

Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock picking...

Shareholder Returns

CEMENTOSCL Basic MaterialsCL Market
7D0%1.6%-0.3%
1Y8.1%12.8%16.9%

Return vs Industry: CEMENTOS underperformed the CL Basic Materials industry which returned 11.9% over the past year.

Return vs Market: CEMENTOS underperformed the CL Market which returned 15.6% over the past year.

Price Volatility

Is CEMENTOS's price volatile compared to industry and market?
CEMENTOS volatility
CEMENTOS Average Weekly Movement0.002%
Basic Materials Industry Average Movement3.9%
Market Average Movement3.0%
10% most volatile stocks in CL Market5.6%
10% least volatile stocks in CL Market1.3%

Stable Share Price: CEMENTOS has not had significant price volatility in the past 3 months compared to the CL market.

Volatility Over Time: CEMENTOS's weekly volatility (0%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1957933Enrique Elsaca Hirmascbb.cl

Cementos Bio Bio S.A. engages in the production and sale of cement, lime, and concrete products in Chile and internationally. The company operates through Cement and Lime segments. It offers ready-mixed concrete, gypsum, and limestone products.

Cementos Bio Bio S.A. Fundamentals Summary

How do Cementos Bio Bio's earnings and revenue compare to its market cap?
CEMENTOS fundamental statistics
Market capCL$457.10b
Earnings (TTM)CL$33.09b
Revenue (TTM)CL$370.54b
13.8x
P/E Ratio
1.2x
P/S Ratio

Is CEMENTOS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CEMENTOS income statement (TTM)
RevenueCL$370.54b
Cost of RevenueCL$227.35b
Gross ProfitCL$143.19b
Other ExpensesCL$110.10b
EarningsCL$33.09b

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)125.23
Gross Margin38.64%
Net Profit Margin8.93%
Debt/Equity Ratio31.8%

How did CEMENTOS perform over the long term?

See historical performance and comparison

Dividends

4.6%
Current Dividend Yield
0%
Payout Ratio

Does CEMENTOS pay a reliable dividends?

See CEMENTOS dividend history and benchmarks
When do you need to buy CEMENTOS by to receive an upcoming dividend?
Cementos Bio Bio dividend dates
Ex Dividend DateMay 19 2026
Dividend Pay DateMay 25 2026
Days until Ex dividend114 days
Days until Dividend pay date108 days

Does CEMENTOS pay a reliable dividends?

See CEMENTOS dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/21 06:42
End of Day Share Price 2026/05/19 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cementos Bio Bio S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide